All Type of News
Screening period of chemically modified drugs to be shortened
Chemically modified drugs and generics will be listed into the national health insurance within 30-60 days and 60-90 days after application, the Health Insurance Review and Assessment Service said on December 22.
T...
Health Insurance to cover Elaprase and Naglazyme
Those who have suffered from Mucopolysaccharidosis II (MPS II) and Mucopolysaccharidosis VI (MPS VI) will be covered by health insurance, the Ministry of Health, Welfare and Family Affairs said on December 22.
Elap...
KFDA to maker public screening review of clinical trial protocol
The Korea Food and Drug Administration unveiled its plan to disclose its screening review concerning protocol, safety and efficacy of drugs, etc. and specification & analytical methods in its web site from next year.
...
CoaguChek system should be covered by health insurance
The national health insurance should cover Roche Diagnostics CoaguCheck system for patients on oral anticoagulant treatment, since it offers a simple, fast, and convenient way of directly monitoring their INR results,...
Huons’s smoking cessation aid debuts in domestic market
Nicopil gum, a new smoking cessation aid of Huons Co., made its debut in the domestic market valued at 20 billion won, the company said on December 23.
The sugar-free gum can give smokers confidence that they could...
KFDA to make public rules on drug safety information management
The Korea Food and Drug Administration says it will publish a guidebook related to the rules concerning drug safety information management.
According to the KFDA, the guidebook covers the detailed procedures to rep...
AZK to lower Crestor price voluntarily
The Health Insurance Review and Assessment Service said on December 19 that it has finalized the assessment of economic effectiveness over Crestor, cholesterol-lowering drug to treat the clogging of arteries, followin...
Health ministry names first president of NECA
The Ministry of Health, Welfare and Family Affairs announced on December 22 that its has appointed Huh Dae-seok, professor of College of Medicine, Seoul National University, as the first president of the National Evid...
SK Chemicals conducts organization reshuffleSK Chemicals has reshuffled its organization into two business units – chemical business and life sciences to develop new growth engines, it was announced on December 19.
The...
|
Kwangdong to introduce new rheumatoid arthritis treatment
Kwangdong Pharm has announced that it has signed an exclusive license agreement with Israel based Can-Fite BioPharma Ltd. to develop and commercialize the drug CF101 for the treatment of rheumatoid arthritis in Korea....
